33例局部晚期肺癌扩大切除手术预后的临床分析

Prognostic Analysis of Extended Resection for Treatment of Patients with Locally Advanced Non-small Cell Lung Cancer

  • 摘要: 目的:分析局部晚期非小细胞肺癌扩大切除手术的预后,探索其合理的手术适应证。方法:对33例扩大切除的NSCLC患者进行随访并回顾性研究。Kaplan-meier法计算生存率,Cox回归计算风险比率(HR)、判定预后因素。结果:5例患者发生严重的围手术期并发症(15.2%),2例患者因并发症死亡(6.1%)。1、3年生存率分别为60.6%和17.7%,中位生存期15个月。N2患者中位生存期为13个月,N0-1患者为24个月(P<0.05)。Cox回归分析显示,腺癌(HR=2.5)和N2(HR=2.9)是独立的预后因素。结论:扩大切除手术是对局部晚期NSCLC可选择的治疗手段之一,但是鉴于手术危险性大、并发症严重,对其手术适应证应谨慎选择。由于预后不良,对腺癌和N2患者不宜首选扩大切除手术。

     

    Abstract: Objective: To analyze the prognostic factors of non-small cell lung cancer (NSCLC) patients after extended resection for locally advanced disease and to investigate reasonable indications for the procedure. Methods: The clinical data of 33 patients that received extended resection on locally advanced NSCLC were reviewed. The survival rate was calculated by Kaplan-meier method, and Cox regression analysis was performed to identify the risk factors. Results: Major perioperative complications were found in 5 patients (15.2%), including 2 patients (6.1%) that died within 3 months of surgery because of postoperative complications. The 1-and 3-year survival rate was 60.6% and 17.7% respectively, with a median survival time of 15 months. The median survival time of 13 months in patients with N2 disease was shorter than the 24 months seen in the N0-1 patients (P<0.05). Adenocarcinoma (HR=2.5) and N2 (HR=2.9) were the risk factors. Conclusion: Extended resection is one of the currently available treatments for locally advanced NSCLC. Because severe postoperative complications may occur following the procedure, patients should be cautious in selection of the extended resection. Because of poorer prognosis, extended resection should not be used for patients with adenocarcinoma and N2 disease.

     

/

返回文章
返回